Comment on Xue et al.: Alendronate treatment improves bone–pedicle screw interface fixation in posterior lateral spine fusion: an experimental study in a porcine model

Autor: Qingyun Xue, Xuenong Zou, Haisheng Li, Finn B. Christensen, Martin Lind, Michel Dalstra, Cody Bünger
Jazyk: angličtina
Rok vydání: 2010
Předmět:
musculoskeletal diseases
medicine.medical_specialty
Bone disease
Swine
medicine.medical_treatment
Osteoporosis
Bone Screws
Dentistry
Lumbar vertebrae
Graft Survival/drug effects
Spinal Fusion/methods
Lumbar Vertebrae/drug effects
Osseointegration
Bone resorption
Bone remodeling
Fixation (surgical)
Alendronate/pharmacology
medicine
Animals
Orthopedics and Sports Medicine
Bone Density Conservation Agents/pharmacology
Letter to the Editor
Bone mineral
Original Paper
Bone Transplantation
Lumbar Vertebrae
Alendronate
Bone Density Conservation Agents
business.industry
Graft Survival
Osseointegration/drug effects
Biomechanics
medicine.disease
equipment and supplies
musculoskeletal system
Surgery
Biomechanical Phenomena
Equipment Failure Analysis
Disease Models
Animal

surgical procedures
operative

medicine.anatomical_structure
Spinal Fusion
Spinal fusion
Orthopedic surgery
Female
business
Zdroj: Xue, Q, Li, H, Zou, X, Dalstra, M, Lind, M, Christensen, F B & Bünger, C 2010, ' Alendronate treatment improves bone-pedicle screw interface fixation in posterior lateral spine fusion: An experimental study in a porcine model ', International Orthopaedics, vol. 34, pp. 447-451 .
Xue, Q, Li, H, Zou, X, Dalstra, M, Lind, M, Christensen, F B & Bünger, C 2010, ' Alendronate treatment improves bone-pedicle screw interface fixation in posterior lateral spine fusion : an experimental study in a porcine model ', International Orthopaedics, vol. 34, no. 3, pp. 447-51 . https://doi.org/10.1007/s00264-009-0759-4
DOI: 10.1007/s00264-009-0759-4
Popis: We read the article entitled “Alendronate treatment improves bone–pedicle screw interface fixation in posterior lateral spine fusion: an experimental study in a porcine model” by Qingyun Xue et al. with great interest [1]. The purpose of the research was to investigate whether alendronate treatment improves bone–pedicle screw interface fixation in posterior lateral spine fusion. We would like to thank the authors for their innovative and encouraging paper, but we have some concerns about the safety profile of alendronate. The authors advocated wider use of alendronate based on the properties of bisphosphonates for reduction of bone remodelling by inhibition of osteoclastic activity. Normal bone remodelling is linked to new bone formation by the so-called coupling phenomenon. The most effective approach to prevent implant loosening would be to have a positive balance between bone formation and resorption in the active bone-remodelling time period. Alendronate treatment could protect the bone structure from extra resorption while maintaining the bone volume around the screw surface. In fact, prolonged suppression of bone remodelling with alendronate may be associated with a new form of insufficiency fracture of femur [2]. The fracture rate is higher in long-term use than during the first year of therapy, suggesting possible adverse effects on bone [3]. Alendronate inhibits bone resorption by suppressing activity of osteoclasts, and inducing them to undergo apoptosis. While this leads to an increase in bone mineral density (BMD) of patients with osteoporosis, treatment with alendronate has been shown to reduce bone turnover. In humans prolonged administration of bisphosphonates can lead to development of osteopetrosis or marble bone disease [4]. Keeping the above-mentioned facts in mind, authors must warn the orthopaedic community about liberal use of alendronate.
Databáze: OpenAIRE